File Download

There are no files associated with this item.

Supplementary

Conference Paper: Tumor suppressor deleted in liver cancer-1 (DLC-1) gene triggers apoptosis in NPC cells by perturbing mitochondria (MI)

TitleTumor suppressor deleted in liver cancer-1 (DLC-1) gene triggers apoptosis in NPC cells by perturbing mitochondria (MI)
Authors
Issue Date2008
PublisherSun Yat-sen University Cancer Center
Citation
The 13th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Guangzhou, China, 7-10 November 2008 How to Cite?
AbstractDLC-1 is a bona fide tumor suppressor gene (TSG) mapped to chromosome 8p22-p21, a region frequently deleted in human malignancies. DLC-1 gene encodes a GTPase activating protein (GAP), which negatively regulates the activity of Ras homolog (Rho) family. RhoGAP activity of DLC-1 plays an important role in regulating cell motility and suppressing cancer metastasis. Genetic and epigenetic inactivation of DLC1 is frequently found in human cancers, including nasopharyngeal carcinoma (NPC) and hepatocellular carcinoma (HCC), two major endemic tumors in southern China. The anti-proliferative effect of DLC-1 is evidenced with its inhibition of colony formation in NPC cells. The pro-apoptotic function of DLC-1 has also been suggested, but the underlying mechanisms remain unanswered. Since the human DLC-1 ortholog, DLC-2 was found to be localized on MI membrane; DLC-1 has been hypothesized to play a role in MI dependent apoptosis. To test this hypothesis, NPC cells were transfected with EGFP-tagged DLC-1 plasmid, and stained with tetramethylrhodamine ethyl ester (TMRE). Microscopically, DLC-1 signal was found to localize in cytoplasm and was significantly overlapped with TMRE signal. In addition, ectopic expression of DLC-1 dropped MI membrane potential (MMP) as evidenced by flow cytometry-based TMRE staining. Furthermore, we demonstrated that blocking of death receptor pathway(DR) by dominant negative FADD failed to suppress DLC-1 mediated MMP changes, suggesting that DLC-1 induced apoptosis was independent to DR pathway. We will next evaluate the effect of blocking stress-induced pathway with specific inhibitors on DLC-1 induced apoptosis. In summary, our results suggest that DLC-1 protein may target to MI membrane and induce apoptosis. The re-expression of DLC-1 is of mild pro-apoptotic activity; and thus it prompted us to test whether DLC-1 would potentiate apoptosis induced by the challenge of genotoxins and death ligands, and our study may provide insights to design of novel therapeutic modality for cancers.
Persistent Identifierhttp://hdl.handle.net/10722/62658

 

DC FieldValueLanguage
dc.contributor.authorZhang, XNen_HK
dc.contributor.authorWong, CMen_HK
dc.contributor.authorHuang, PCen_HK
dc.contributor.authorHuang, WLen_HK
dc.date.accessioned2010-07-13T04:06:07Z-
dc.date.available2010-07-13T04:06:07Z-
dc.date.issued2008en_HK
dc.identifier.citationThe 13th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Guangzhou, China, 7-10 November 2008-
dc.identifier.urihttp://hdl.handle.net/10722/62658-
dc.description.abstractDLC-1 is a bona fide tumor suppressor gene (TSG) mapped to chromosome 8p22-p21, a region frequently deleted in human malignancies. DLC-1 gene encodes a GTPase activating protein (GAP), which negatively regulates the activity of Ras homolog (Rho) family. RhoGAP activity of DLC-1 plays an important role in regulating cell motility and suppressing cancer metastasis. Genetic and epigenetic inactivation of DLC1 is frequently found in human cancers, including nasopharyngeal carcinoma (NPC) and hepatocellular carcinoma (HCC), two major endemic tumors in southern China. The anti-proliferative effect of DLC-1 is evidenced with its inhibition of colony formation in NPC cells. The pro-apoptotic function of DLC-1 has also been suggested, but the underlying mechanisms remain unanswered. Since the human DLC-1 ortholog, DLC-2 was found to be localized on MI membrane; DLC-1 has been hypothesized to play a role in MI dependent apoptosis. To test this hypothesis, NPC cells were transfected with EGFP-tagged DLC-1 plasmid, and stained with tetramethylrhodamine ethyl ester (TMRE). Microscopically, DLC-1 signal was found to localize in cytoplasm and was significantly overlapped with TMRE signal. In addition, ectopic expression of DLC-1 dropped MI membrane potential (MMP) as evidenced by flow cytometry-based TMRE staining. Furthermore, we demonstrated that blocking of death receptor pathway(DR) by dominant negative FADD failed to suppress DLC-1 mediated MMP changes, suggesting that DLC-1 induced apoptosis was independent to DR pathway. We will next evaluate the effect of blocking stress-induced pathway with specific inhibitors on DLC-1 induced apoptosis. In summary, our results suggest that DLC-1 protein may target to MI membrane and induce apoptosis. The re-expression of DLC-1 is of mild pro-apoptotic activity; and thus it prompted us to test whether DLC-1 would potentiate apoptosis induced by the challenge of genotoxins and death ligands, and our study may provide insights to design of novel therapeutic modality for cancers.-
dc.languageengen_HK
dc.publisherSun Yat-sen University Cancer Center-
dc.relation.ispartofThe Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases-
dc.titleTumor suppressor deleted in liver cancer-1 (DLC-1) gene triggers apoptosis in NPC cells by perturbing mitochondria (MI)en_HK
dc.typeConference_Paperen_HK
dc.identifier.emailWong, CM: jackwong@pathology.hku.hken_HK
dc.identifier.hkuros153959en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats